https://www.indianpharmapost.com/punjab-joins-hands-with-roche-to-roll-out-neurosakhi-for-women-with-multiple-sclerosis-193322026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/kainova-reports-positive-phase-i-results-for-receptor-antagonist-targeting-advanced-tumors-193432026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/enterobiotix-completes-enrollment-in-landmark-microbiome-trial-for-stem-cell-transplant-patients-193422026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-nod-to-first-treatment-for-rare-genetic-brain-disorder-193412026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/vertex-pharmaceuticals-new-kidney-drug-shows-dramatic-results-in-phase-3-trial-193402026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-nod-to-lifevac-de-novo-paving-for-next-generation-anti-choking-device-193392026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/newcelx-and-eledon-join-forces-to-advance-potential-type-1-diabetes-cure-193382026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/agilent-to-acquire-biocare-medical-for-950m-supercharging-cancer-diagnostics-portfolio-193372026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/india-tackles-rare-diseases-head-on-at-landmark-summit-in-new-delhi-193362026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/bpl-medical-tech-acquires-south-koreas-yozma-bmtech-193352026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/world-glaucoma-week-experts-sound-alarm-over-millions-of-undiagnosed-cases-in-india-193342026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/fortis-launches-4-specialized-clinics-in-bengaluru-to-tackle-under-discussed-health-issues-193332026-03-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-boosts-companion-diagnostics-with-ai-powered-cgm-diasens-and-glucolive-launch-193442026-03-12T00:00:00+05:30always0.9